Show simple item record

dc.contributor.authorOrtenzi, Marco Aldo
dc.contributor.authorMolino, Silvia
dc.contributor.authorRufián Henares, José Ángel
dc.identifier.citationOrtenzi, M.A.; Antenucci, S.; Marzorati, S.; Panzella, L.; Molino, S.; Rufián-Henares, J.Á.; Napolitano, A.; Verotta, L. Pectin-Based Formulations for Controlled Release of an Ellagic Acid Salt with High Solubility Profile in Physiological Media. Molecules 2021, 26, 433.
dc.description.abstractAmong bioactive phytochemicals, ellagic acid (EA) is one of the most controversial because its high antioxidant and cancer-preventing effects are strongly inhibited by low gastrointestinal absorption and rapid excretion. Strategies toward an increase of solubility in water and bioavailability, while preserving its structural integrity and warranting its controlled release at the physiological targets, are therefore largely pursued. In this work, EA lysine salt at 1:4 molar ratio (EALYS), exhibiting a more than 400 times increase of water solubility with respect to literature reports, was incorporated at 10% in low methoxylated (LM) and high methoxylated (HM) pectin films. The release of EA in PBS at pH 7.4 from both film preparations was comparable and reached 15% of the loaded compound over 2 h. Under simulated gastric conditions, release of EA from HM and LM pectin films was minimal at gastric pH, whereas higher concentrations—up to 300 µM, corresponding to ca. 50% of the overall content—were obtained in the case of the HM pectin film after 2 h incubation at the slightly alkaline pH of small intestine environment, with the enzyme and bile salt components enhancing the release. EALYS pectin films showed a good prebiotic activity as evaluated by determination of short chain fatty acids (SCFAs) levels following microbial fermentation, with a low but significant increase of the effects produced by the pectins themselves. Overall, these results highlight pectin films loaded with EALYS salt as a promising formulation to improve administration and controlled release of the compound.es_ES
dc.description.sponsorshipEuropean Union’s Horizon 2020 research and innovation program through the Stance4Health project (Grant No. 816303)es_ES
dc.rightsAtribución 3.0 España*
dc.subjectEllagic acid lysine saltes_ES
dc.subjectPectin-based formulationses_ES
dc.subjectControlled releasees_ES
dc.subjectGut microbiotaes_ES
dc.titlePectin-Based Formulations for Controlled Release of an Ellagic Acid Salt with High Solubility Profile in Physiological Mediaes_ES

Files in this item


This item appears in the following Collection(s)

Show simple item record

Atribución 3.0 España
Except where otherwise noted, this item's license is described as Atribución 3.0 España